Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin Lymphoma
Conclusions:
FMT may be a feasible option for treatment of refractory CDI in pediatric oncology patients.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Clinical and Laboratory Observations Source Type: research
More News: Cancer & Oncology | Chemotherapy | Gastroenterology | Hematology | Hodgkin's Disease | Laboratory Medicine | Lymphoma | Non-Hodgkin's Lymphoma | Pediatrics | Transplants